Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 17/20 | 0.69 |
| ▸ | CCNT1 | O60563 | 17/20 | 0.69 |
| ▸ | CDK9 | P50750 | 17/20 | 0.69 |
| ▸ | CDK1 | P06493 | 13/20 | 0.69 |
| ▸ | CCNB1 | P14635 | 13/20 | 0.69 |
| ▸ | CDK7 | P50613 | 12/20 | 0.69 |
| ▸ | CCNH | P51946 | 12/20 | 0.69 |
| ▸ | CCNE1 | P24864 | 11/20 | 0.69 |
| ▸ | CDK4 | P11802 | 10/20 | 0.69 |
| ▸ | CCND1 | P24385 | 8/20 | 0.69 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.51 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.51 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.51 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.51 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2285893 | 0.90 | CDK2 (0.71) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2289225 | 0.87 | CDK2 (0.67) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2354910 | 0.87 | IGF1R (0.53) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2354899 | 0.86 | CDK2 (0.63) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2286073 | 0.85 | CDK2 (0.53) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2282896 | 0.85 | CDK2 (0.51) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2281811 | 0.85 | CDK2 (0.49) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2357383 | 0.84 | CDK2 (0.77) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL1531457 | 0.82 | CDK2 (1.00) | CDK2CCNT1CDK9CDK1CCNB1 | |
| SCHEMBL2356635 | 0.81 | CDK2 (0.53) | CDK2CCNT1CDK9CDK1CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2011-08-11 | — | — | US | disclosed |
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, RDX | CDK2 2065/4885CCNT1 513/4885CDK9 3151/4885 |
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, CYP3A4 | CDK2 2144/4885CCNT1 528/4885CDK9 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.